Pricing Log in Create free account

Moolec Science SA (MLEC) vs Atrinsic Inc. (PTIX)

Moolec Science SA and Atrinsic Inc. are both Biotechnology companies. Moolec Science SA and Atrinsic Inc. are of similar size ($1.4M and $1.3M). Moolec Science SA has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.3×. Atrinsic Inc. has the higher net margin (0.00% vs −7.18%) and the lower return on invested capital (−229.9% vs 0.00%). Across the 13 metrics below, Moolec Science SA leads on 7 and Atrinsic Inc. on 6.

Valuation

Metric MLEC PTIX Biotechnology median
P/E n/m 0.34 8.50
P/S 0.00 n/m 9.71
P/B 0.03 0.79 2.13
Price to free cash flow 0.02 n/m 20.82
EV/EBITDA 1.76 n/m 0.64
EV/Sales 0.14 n/m 9.21
Earnings yield (4,665.32%) 297.33% (33.15%)
Free cash flow yield 4,200.26% (158.74%) (25.50%)

Profitability

Metric MLEC PTIX Biotechnology median
Gross margin 39.67% 0.00% 65.16%
Operating margin 4.09% 0.00% 0.00%
Net margin (7.18%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (338.24%) (56.36%)
Return on assets 0.00% 378.63% (48.04%)
Return on invested capital 0.00% (229.86%) 0.00%

Growth

Metric MLEC PTIX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (447.53%) 188.24% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLEC PTIX Biotechnology median
Debt to equity 4.37 0.00 0.00
Current ratio 0.15 0.66 4.72
Net debt to EBITDA (2.73) 0.52 0.96

Dividend

Metric MLEC PTIX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MLEC PTIX Biotechnology median
Market cap 1.36m 1.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack